Cornerstone Planning Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Cornerstone Planning Group's GILD Position: Q2 2026 in Review
Cornerstone Planning Group reduced its Gilead Sciences (GILD) stake by 7.5% in Q2 2026, selling an estimated $9.49K and leaving 883 shares worth $115K. The position accounts for 0.01% of the portfolio, ranked #226.
Cornerstone Planning Group first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $127K in Q1 2026. 1,416 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Cornerstone Planning Group held 883 shares of Gilead Sciences worth $115K as of Q2 2026.
- Cornerstone Planning Group sold 72 Gilead Sciences shares in Q2 2026, an estimated $9.49K.
- Gilead Sciences made up 0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #226 holding.
- Cornerstone Planning Group first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
- Cornerstone Planning Group's Gilead Sciences position peaked at $127K in Q1 2026.
- 1,416 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.